Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 29/01/2020.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | date du courrier |
1 | RILAMIG | FROVATRIPTAN | 2.5mg | COMP PEL | B/2 | Menarini International Operation Luxembourg S.A | E | N | 31/07/2019 |
2 | DROPERIDOL AGUETTANT | DROPERIDOL | 1.25 mg/ml | SOL INJ | B/10 AMP | AGUETTANT | E | N | 07/08/2019 |
3 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/10ml | GE Healthcare Norvège | E | N | 03/09/2019 |
4 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/15ml | GE Healthcare Norvège | E | N | 03/09/2019 |
5 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/20ml | GE Healthcare Norvège | E | N | 03/09/2019 |
6 | NUTRIFLEX LIPID PERI | AA + G + LIP + ELECTROLYTES | 1875 ml | EMULSION INJ | POCHE/ 1875 ml | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
7 | NUTRIFLEX LIPID PERI | AA + G + LIP + ELECTROLYTES | 2500 ML | EMULSION INJ | POCHE/ 2500 ML | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
8 | NUTRIFLEX LIPID PERI | AA + G + LIP + ELECTROLYTES | 1250 ML | EMULSION INJ | POCHE/ 1250ML | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
9 | NUTRIFLEX LIPID PLUS | AA + G + LIP + ELECTROLYTES | 2500 ML | EMULSION INJ | POCHE/ 2500 ML | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
10 | NUTRIFLEX LIPID PLUS | AA + G + LIP + ELECTROLYTES | 1875 ML | EMULSION INJ | POCHE/ 1875 ML | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
11 | NUTRIFLEX LIPID PLUS | AA + G + LIP + ELECTROLYTES | 1250 ML | EMULSION INJ | POCHE/ 1250ML | B.BRAUN Melsungen AG | V | N | 13/09/2019 |
12 | STODALINE SANS SUCRE | PRODUITS HOMEOPATHIQUES | SIROP | FL/200 ML | BOIRON | C | N | 19/09/2019 | |
13 | SUXAMETHONIUM CHLORID VUAB | SUXAMETHONIUM | 100 mg | PDRE P SUSP INJ | B/1FL | VUAB PHARMA AS | V | N | 20/09/2019 |
14 | GAZYVARO | OBINUTUZUMAB | 1000MG/40ML | SOL INJ | B/1FL/40ML | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | E | N | 25/09/2019 |
15 | LOTEMAX | LOTEPREDNOL | 0.5% | GEL OPHTALMIQUE | FL /10ml | BAUSCH AND LOMB | E | N | 29/09/2019 |
16 | RELVAR ELLIPTA | FUROATE DE FLUTICASONE/VILANTEROL | 92/22µg | PDRE PR INHALATION BUCCALE | B/1 INH DE 30 DOSES | GALAXO GROUP LTD | E | V | 30/09/2019 |
17 | RELVAR ELLIPTA | FUROATE DE FLUTICASONE/VILANTEROL | 184/22µg | PDRE PR INHALATION BUCCALE | B/1 INH DE 30 DOSES | GALAXO GROUP LTD | E | V | 30/09/2019 |
18 | STELARA | USTEKINUMAB | 45 mg/0.5ml | SOL INJ | B/1FL/0.5ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
19 | STELARA | USTEKINUMAB | 45 mg/0.5ml | SOL INJ | B/1seringue pré-remplie/0.5ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
20 | STELARA | USTEKINUMAB | 130mg/26ml | SOL INJ PR PERF | B/1FL/30ML | Janssen-Cilag International N.V | E | N | 01/10/2019 |
21 | STELARA | USTEKINUMAB | 90mg/ml | SOL INJ | B/1Seringue pré-remplie/1ml | Janssen-Cilag International N.V | E | N | 01/10/2019 |
22 | PMS-RISEDRONATE | RISEDRONATE | 35 mg | COMP PEL | B/4 | PHARMASCIENCE INC CANADA | E | N | 02/10/2019 |
23 | PROLUTEX | PROGESTERONE | 25mg | SOL INJ | B/7Flacons | IBSA Institut Biochimique SA | E | N | 02/10/2019 |
24 | AKYNZEO | NETUPITANT+PALONOSETRON | 300mg/ 0.5mg | GELLULE | B/1 | HELSINN BIREX Pharmaceuticals Ltd | E | N | 07/10/2019 |
25 | TARGINACT | OXYCODONE+ NALOXONE | 40mg/20mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
26 | TARGINACT | OXYCODONE+ NALOXONE | 20mg/10mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
27 | TARGINACT | OXYCODONE+ NALOXONE | 10mg/5mg | COMP | B/56 | Napp Pharmaceuticals Limited | V | N | 08/10/2019 |
28 | ALDARA | IMIQUIMOD | 5% | CREME DERMIQUE | B/12 Sachets Unidoses/250 mg | MEDA AB | E | N | 09/10/2019 |
29 | RANEXA | RANOLAZINE | 500 mg | COMP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 23/10/2019 |
30 | RANEXA | RANOLAZINE | 750 mg | COMP | B/60 | Menarini International Operation Luxembourg S.A | E | N | 23/10/2019 |
31 | MYDRANE | TROPICAMIDE+ CHLORHYDRATE DE PHENYLEPHRINE+ CHLORHYDRATE DE | 0.2mg/ml+ 3.1mg/ml+ 10mg/ml | AMPOULE | B/20 Ampoules de 1 ml + 20 aiguilles | THEA | I | N | 24/10/2019 |
32 | HUMIRA | ADALIMUMAB | 40 mg | SERINGUE | B/2 seringues/0.4 ml | ABBVIE DEUTSCHLAND Gmbh and Co.KG | E | N | 29/10/2019 |
33 | LIPANTHYL | FENOFIBRATE | 145 mg | COMP PEL | B/30 | MYLAN MEDICAL SAS | E | N | 29/10/2019 |
34 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
35 | INLYTA | AXITINIB | 5 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
36 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/56 | PFIZER AG | V | N | 20/11/2019 |
37 | INLYTA | AXITINIB | 1 mg | COMP PEL | B/28 | PFIZER AG | V | N | 20/11/2019 |
38 | EYLEA | AFLIBERCEPT | 40 mg/ml | SOL INJ | FL/ 100 ml | BAYER AG Leverkusen | N | 30/12/2019 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | TOBRADEX | DEXAMETHASONE +TOBRAMYCINE | 100 MG/300MG | COLLYRE | B/1F | NOVARTIS | E | N | CS 09/07/2019 |
2 | DAISYNELLE | DESOGESTREL+ ETHINYLOESTRADIOL | 150/20µG | COMPRIME | B/21 | STRAGEN | E | N | 18/07/2019 |
3 | ARNICA COMPLEXE N01 | ARNICA | SOL BUVABLE EN GOUTTES | FL/30ML | LEHNING | C | N | 18/07/2019 | |
4 | ADOL | PARACETAMOL | 100MG/ML | GOUTTES BUVABLES | FL/15ML | JULPHAR | E | V | 18/07/2019 |
5 | STOCRIN | EFAVIRENZ | 600 mg cp pell FL/630 | SOL BUV | B/1FL/180 ml | MERCK SHARP &DOHME BV | E | N | TRANSFERT 22/07/2019 |
6 | Cyclogest | Progesterone | 200 mg | Suppositoires | B/15 | ld Collins UK | N/T | 22/07/20219 | |
7 | OCREVUS | OCRELIZUMAB | 300 MG | SOL INJ PERF | B/1FL/10ML | ROCHE PHARMA (SCHWEIZ) LTD SUISSE | V | N | 29/07/2019 |
8 | GENSULIN R | INSULINE HUMAINE | 100UI/ML | SOL INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
9 | GENSULIN M30 (30/70) | INSULINE HUMAINE | 100UI/ML | SUSP INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
10 | GENSULIN N | INSULINE HUMAINE | 100UI/ML | SUSP INJ | B/5Cartouches/3ML | BIOTON S.A | V | N | 29/07/2019 |
11 | BENMAK | CHLORHYDRATE DE BENDAMUSTINE | 25 MG (2.5mg/ml) | pdre pr sol perf | B/5FL/10ML | MAKPHARM D.O.O | E | N | 30/07/2019 |
12 | BENMAK | CHLORHYDRATE DE BENDAMUSTINE | 100 MG (2.5mg/ml) | pdre pr sol perf | B/5FL/40ML | MAKPHARM D.O.O | E | N | 30/07/2019 |
13 | SEVOFLURANE USP | SEVOFLURANE | liquide pr inhalation | B/1FL/250ML | PIRAMAL CRITICAL CARE INC | V | N | 30/07/2019 | |
14 | MYCOPHENOLATE MOFETIL ACCORD | MYCOPHENOLATE MOFETIL | 500 MG | GELULE | B/50 | ACCORD HEALTHCARE LTD | C | N | |
15 | MYCOPHENOLATE MOFETIL ACCORD | MYCOPHENOLATE MOFETIL | 250 MG | GELULE | B/50 | ACCORD HEALTHCARE LTD | C | N | |
16 | AERIUS | DESLORATADINE | 5 MG | SIROP | B/1 | Merck Sharp & Dohme Ltd R.U | E | N | 16/08/2019 |
17 | REVLIMID | LENALIDOMIDE | 15 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
18 | REVLIMID | LENALIDOMIDE | 10 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
19 | REVLIMID | LENALIDOMIDE | 25 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
20 | REVLIMID | LENALIDOMIDE | 5 MG | GELULE | B/21 | Celgene Europe B.V. | E | N | TRANSFERT 20/08/2019 |
21 | ZINFORO | CEFTAROLINE FOSAMIL | 600 MG | PDRE PR SOL PERFUSION | B/10F | PFIZER Ireland Pharmaceuticals | E | N | TRANSFERT 27/08/2019 |
22 | GONAL F PEN | FOLLITROPINE | 900 UI/1.5 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +20 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
23 | GONAL F PEN | FOLLITROPINE | 450 UI/0,75 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +12 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
24 | GONAL F PEN | FOLLITROPINE | 300 UI/0,5 ml | SOL INJ | B/1stylo pré-rempli/1.5 ml +8 auig | MERCK EUROPE B.V | E | N | 29/08/2019 TRANSFERT AVEC VARIATION |
25 | CEBESINE | OXYBUPROCAINE | 0.4% | COLLYRE | FL/5ML | CHAUVIN | I | N | 03/09/2019 Extention de présentation avec changement d cond I |
26 | REBIF | INTERFERON BETA-1A | 44 µg/0.5 ml | SOL INJ | B/4 cartouches/1.5 ml | MERCK EUROPE B.V | E | N | TRANSFERT 04/09/2019 |
27 | REBIF | INTERFERON BETA-1A | 22 µg/0.5 ml | SOL INJ | B/4 cartouches/1.5 ml | MERCK EUROPE B.V | E | N | TRANSFERT 04/09/2019 |
28 | VFEND | VORICONAZOLE | 40 MG/ML | PDRE PR SUSP ORALE | B/1FL DE45G | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 05/09/2019 |
29 | RAPAMUNE | SIROLIMUS | 1 MG | COMP ENROBE | B/30 | PFIZER S.A BELGIQUE | E | N | TRANSFERT 16/09/2019 |
30 | VFEND | VORICONAZOLE | 200MG | COMP PELLICULE | B/14 | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 19/09/2019 |
31 | VFEND | VORICONAZOLE | 50 MG | COMP PELLICULE | B/28 | PFIZER EUROPE MA EEIG | E | N | TRANSFERT 19/09/2019 |
32 | DIAMOX 250 MG | ACETAZOLAMIDE | 250 mg | COMP | B/24 | COOPERATION PHARMACEUTIQUE FRANCAISE | E | N | TRANSFERT 09/10/2019 |
33 | ZAVICEFTA | CEFTAZIDIME+ AVIBACTAM | 2g/0.5g | PDRE PR SOL PERF | B/10FL | PFIZER Ireland Pharmaceuticals | N | 22/10/2019 | |
34 | SUTENT | SUNITINIB | 12.5 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
35 | SUTENT | SUNITINIB | 25 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
36 | SUTENT | SUNITINIB | 50 mg | GELULE | B/28 | PFIZER Europe MA EEIG | E | N | Transfert 29/10/2019 |
37 | DYNASTAT | PARECOXIB | 40MG | PDRE PR SOL INJ | B/10F | PFIZER Europe MA EEIG | E | N | TRANSFERET 29/10/2019 |
38 | SOOLANTRA | IVERMECTINE | 10mg/gr | CREME DERMIQUE | B/1tube de 15gr | GALDERMA INTERNATIONAL | C | N | 11/11/2019 |
39 | SERESTA | OXAZEPAM | 50 MG | COMP | B/20 | BIODIM | I | N | 11/11/2019 |
40 | SERESTA | OXAZEPAM | 10 MG | COMP | B/30 | BIODIM | I | N | 11/11/2019 |
41 | MINESSE | ETHINYLESTRADIOL+GESTODENE | 60µg/15µg | COMP PELLICULE | B/28 | PFIZER HOLDING | E | V | 14/11/2019 changement de la composition |
42 | TOBRADEX | DEXAMETHASONE+TOBRAMYCINE | Tube/3.5 gr | pommade ophtalmo | Tube | NOVARTIS PHARMA SCHWEIZ AG | E | N | Transfert avec variation 14/11/2019 |
43 | REBIF | INTERFERON BETA-1A | 12 MUI/0.5 ml | SERINGUE PRE REMPL | B/12 seringues/0.5ML | MERCK EUROPE B.V | E | N | TRANSFERT 15 /11/2019 |
44 | ULTRA-LEVURE | SACCHAROMYCES BOULARDII | 200 mg | GELULE | FL/30 | BIOCODEX | I | N | 18/11/2019 |
45 | BRINTELLIX | VORTIOXETINE | 10 MG | COMP PELLICULE | B/28 | H.LUNDBECK A/S | E | N | CS 25/11/2019 |
46 | ZELDOX | ZIPRASIDONE | 20 MG/ML | PDRE PR PREP INJ | B/1FL+S/1,2ML | PFIZER GMbH | E | V | CS 25/11/2019 |
47 | ABILIFY | ARIPIPRAZOLE | 15 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
48 | ABILIFY | ARIPIPRAZOLE | 10 MG | COMP | B/28 | ABDI IBRAHIM OTSUKA | E | V | CS 25/11/2019 |
49 | GILENYA | FINGOLIMOD | 0,5 MG | GELULE | B/28 | NOVARTIS PHARMA | V | CS 25/11/2019 | |
50 | UTROGESTAN | PROGESTERONE | 100 MG | CAPSULE MOLLE | B/30 | BESINS INT | E | V | CS 26/11/2019 |
51 | RHOPHYLAC | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG/2ML | SERINGUE PRE REMPL | B/1 | CSL BEHRINGER | E | V | CS 26/11/2019 |
52 | CRESTOR | ROSUVASTATINE | 5 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
53 | CRESTOR | ROSUVASTATINE | 20 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
54 | CRESTOR | ROSUVASTATINE | 10 MG | COMP PELLICULE | B/30 | ASTRAZENECA | E | V | CS 26/11/2019 |
55 | TRESIBA | INSULINE DEGLUDEG | 200 UI/ML | SOL INJ | B/3 | NOVO NORDISK | V | V | CS 26/11/2019 |
56 | TRESIBA FLEXTOUCH | INSULINE DEGLUDEG | 100 UI/ML | SOL INJ | B/5 | NOVO NORDISK | V | V | CS 26/11/2019 |
57 | XELJANZ | TOFACITINIB | 5 MG | COMP PELLICULE | B/60 | PF PRISM C,V C/O PFIZER NETHERLANDS | E | V | CS 26/11/2019 |
58 | IMMUNORHO | IMMUNOGLOBUNE HUMAINE ANTI D | 300µG | PDRE PR PREP INJ | B/1FL | KEDRION S.P.A | E | V | CS 26/11/2019 |
59 | COMBIVIR | LAMIVUDINE+ZIDOVUDINE | 150mg/300mg | COMP PELLICULE SECABLE | B/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
60 | EPIVIR | LAMIVUDINE | 150 mg | COMP PELLICULE SECABLE | FL/60 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
61 | RETROVIR | ZIDOVUDINE | 100 mg | GELULE | B/100 | ViiV Healthcare BV | E | N | TRANSFERT 26/11/2019 |
62 | TOBREX | TOBRAMYCINE | 0.3% | COLLYRE | FL/5ML | NOVARTIS PHARMA AG (Bâle Suisse) | E | V | TRANSFERT avec variation 27/11/2019 |
63 | KISQALI | RIBOCICLIB SUCINATE | 200 MG | COMP PEL | B/63 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 05/12/2019 |
64 | RAPIFEN | ALFENTANIL | 1 mg (0.5mg/ml) | SOL INJ | B/5/2 ML | Piramal Critical Care Limited | V | N | TRANSFERT 06/12/2019 |
65 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/5ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
66 | DARZALEX | Daratumumab | 20mg/ml | SOL INJ | B/1FL/20ML | Janssen-Cilag International N.V | N | CS 03/12/2019 | |
67 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PELL | B/14 | ABBVIE DEUTSCHLAND Gmbh and Co.KG | N | CS 03/12/2019 | |
68 | PURINETHOL | MERCAPTOPURINE | 50 MG | COMP SECABLE | FL/25 | ASPEN PHARMA | V | V | CS 03/12/2019 |
69 | TASIGNA | NILOTINIB | 150 mg | GELULE | B/112 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
70 | TASIGNA | NILOTINIB | 200 mg | GELULE | B/28 | NOVARTIS PHARMA | V | V | CS 03/12/2019 |
71 | IMBRUVICA | IBRUTINIB | 140 MG | GELULE | B/90 | Janssen-Cilag International N.V | E | V | CS 03/12/2019 |
72 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
73 | VENCLYXTO | VENETOCLAX | 50 mg | COMP PEL | B/7 | ABBVIE ltd | N | CS 03/12/2019 | |
74 | VENCLYXTO | VENETOCLAX | 10 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
75 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/14 | ABBVIE ltd | N | CS 03/12/2019 | |
76 | VENCLYXTO | VENETOCLAX | 100 mg | COMP PEL | B/112 | ABBVIE ltd | N | CS 03/12/2019 | |
77 | ZIAGEN | ABACAVIR | 300 mg | COMP PEL | B/60 | ViiV Healthcare BV | E | N | Transfert 04/12/2019 |
78 | VIAGRA | SILDENAFIL | 25 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 09/12/2019 |
79 | VIAGRA | SILDENAFIL | 50 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
80 | VIAGRA | SILDENAFIL | 100 MG | COMP PEL | B/4 | PFIZER Europe MA EEIG | c | N | TRANSFERT 16/12/2019 |
81 | INVANZ | ERTAPENEM | 1 GR | PDRE PR PREP INJ | B/1F/15ML | Merck Sharp & Dohme Ltd R.U | E | N | CS 20/12/2019 |
82 | RIFOCINE | RIFAMYCINE | 250 MG | SOL INJ | B/1FL/3ML | SANOFI AVENTIS SPA | E | V | CS 20/12/2019 |
83 | PREVENAR 13 | VACCIN PNEUMOCOCCIQUE | NA | SUSP INJ | B/1seringue pré-remplie/0.5ml | PFIZER Europe MA EEIG | I | N | TRANSFERT 20/12/2019 |
84 | SOLICARE | SOLIFENACINE SUCCINATE | 5 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
85 | SOLICARE | SOLIFENACINE SUCCINATE | 10 mg | COMP PEL | B/30 | GENEPHARM S.A | E | N | 20/12/2019 |
86 | RILUZOLE MYLAN 50 | RILUZOLE | 50 mg | COMP PEL | B/56 | MYLAN S.A.S | E | N | 24/12/2019 |
87 | DUPHASTON | DYDROGESTERONE | 10 MG | COMP | B/10 | Abbott B.V | E | N | TRANSFERT 25/12/2019 |
88 | RHESONATIV | IMMUNOGLOBUNE HUMAINE ANTI D | 625 UI/ML | SOL INJ | B/1/2ML | OCTAPHARMA | E | V | 25/12/2019 |
89 | KETODERM 2% GEL EN SACHET | KETOCONAZOLE | 2% | GEL DERMIQUE | B/8/6 GR | EG LABO - Laboratoires Eurogenerics SAS | E | N | TRANSFERT 31/12/2019 |
90 | XOLAIR | OMALIZUMAB | 150 mg | PDRE PR SOL INJ | B/1F | NOVARTIS PHARMA AG | V | CS 06/01/2020 | |
91 | BRICANYL LP | TERBUTALINE | 5 MG | COMP LP | FL/60 | ASTRA ZENECA | E | V | CS 06/01/2020 |
92 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
93 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/60 | Bristol-Myers Squibb/Pfizr EEIG | E | N | CS 06/01/2020 |
94 | ELIQUIS | APIXABAN | 2,5MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
95 | ELIQUIS | APIXABAN | 5 MG | COMP PEL | B/20 | Bristol-Myers Squibb/Pfizr EEIG | E | N | TRANSFERT CS 06/01/2020 |
96 | SUXAMETHONIUM-LABESFAL | SUXAMETHONIUM | 100 MG/2ML | SOL INJ | B/100/2ML | LABESFAL | V | V | CS 06/01/2020 |
97 | DESLORATADINE GENEPHARM | DESLORATADINE | 5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
98 | DESLORATADINE GENEPHARM | DESLORATADINE | 2,5 MG | COMP | B/30 | GENEPHARM S.A | E | N | 15/01/2020 |
99 | LEVONORGESTREL MYLAN | LEVONORGESTREL | 1.5 mg | COMP | B/1 | MYLAN S.A.S | E | N | 15/01/2020 |
100 | VAXIGRIP | VACCIN ANTIGRIPPE | SUSP INJ | B/1SER/0,5 ML | SANOFI PASTEUR SA | I | V | CS 17/01/2020 | |
101 | JADENU | DEFERASIROX | 360MG | COMP PEL | B/30 | NOVARTIS PHARMA SCHWEIZ AG | V | N | 22/01/2020 |
102 | JADENU | DEFERASIROX | 180MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
103 | JADENU | DEFERASIROX | 90MG | COMP PEL | B/90 | NOVARTIS PHARMA | V | N | 22/01/2020 |
104 | VESOMNI | SOLIFENACINE+ TAMSULOSINE | 6mg/0.4mg | COMP | B/30 | ASTELLAS PHARMA EUROPE B.V HOLLANDE | N | 22/01/2020 | |
105 | TOMEC | DORZOLAMIDE+ TIMOLOL | 100 mg/ 25mg | COLLYRE | FL/5 ml | ABDI IBRAHIM IIac San. ve Tic. A.S. | E | N | 22/01/2020 |